Literature DB >> 17953726

Growth and neurodevelopment outcome of very low birth weight infants delivered by preeclamptic mothers.

Rita C Silveira1, Renato S Procianoy, Maike S Koch, Ana Cláudia W Benjamin, Carolina F Schlindwein.   

Abstract

AIM: To investigate growth and neurodevelopment outcome of very low birth weight (VLBW) infants delivered by preeclamptic mothers.
METHODS: A cohort including all VLBW infants delivered between December 2003 and May 2005 was followed up to 12 and 18 months corrected age (CA). EXCLUSION CRITERIA: death before 1 year corrected age, major malformations, deafness and blindness. Weight, length and head circumference were plotted on NCHS curves. Bayley Scales were performed at 12 and 18 months CA.
RESULTS: 40 infants in preeclamptic and 46 in control groups were studied. Birth weight and gestational age were 1148 g+/-236 and 1195 g+/-240, and 31.3 weeks+/-1 and 30.6 weeks+/-2 for preeclamptic and control groups, respectively. At 12 and 18 months, CA, weight for age (Z score) was significantly higher in control than in preeclamptic. PDI scores were higher in preeclamptic than in controls at 18 months CA.
CONCLUSIONS: Catch-up of body weight did not occur in the first 18 months CA in preeclamptic infants. Neurodevelopment outcome was better in infants delivered by preeclamptic mothers than in controls at 18 months CA.

Entities:  

Mesh:

Year:  2007        PMID: 17953726     DOI: 10.1111/j.1651-2227.2007.00552.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Causal inference in studies of preterm babies: a simulation study.

Authors:  J M Snowden; O Basso
Journal:  BJOG       Date:  2017-10-30       Impact factor: 6.531

2.  Pregnancy-induced hypertension and neonatal outcomes: a systematic review and meta-analysis.

Authors:  A Razak; A Florendo-Chin; L Banfield; M G Abdul Wahab; S McDonald; P S Shah; A Mukerji
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

3.  Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis.

Authors:  Gillian M Maher; Gerard W O'Keeffe; Patricia M Kearney; Louise C Kenny; Timothy G Dinan; Molly Mattsson; Ali S Khashan
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

4.  Maternal medical conditions during pregnancy and gross motor development up to age 24 months in the Upstate KIDS study.

Authors:  Akhgar Ghassabian; Rajeshwari Sundaram; Amanda Wylie; Erin Bell; Scott C Bello; Edwina Yeung
Journal:  Dev Med Child Neurol       Date:  2015-10-26       Impact factor: 5.449

Review 5.  Maternal preeclampsia and neonatal outcomes.

Authors:  Carl H Backes; Kara Markham; Pamela Moorehead; Leandro Cordero; Craig A Nankervis; Peter J Giannone
Journal:  J Pregnancy       Date:  2011-04-04

6.  Hypertensive disorders in pregnancy and child development at 36 months in the All Our Families prospective cohort study.

Authors:  Natalie V Scime; Erin Hetherington; Lianne Tomfohr-Madsen; Alberto Nettel-Aguirre; Kathleen H Chaput; Suzanne C Tough
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

Review 7.  A review of infant growth and psychomotor developmental outcomes after intrauterine exposure to preeclampsia.

Authors:  Priya Vakil; Amanda Henry; Maria E Craig; Megan L Gow
Journal:  BMC Pediatr       Date:  2022-08-30       Impact factor: 2.567

8.  Association of gestational hypertension and preeclampsia with offspring adiposity: A systematic review and meta-analysis.

Authors:  Shiyu Yan; Jinlang Lyu; Zheng Liu; Shuang Zhou; Yuelong Ji; Haijun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-23       Impact factor: 6.055

9.  Prospective assessment of neurodevelopment in children following a pregnancy complicated by severe pre-eclampsia.

Authors:  Chelsie Warshafsky; Jessica Pudwell; Mark Walker; Shi-Wu Wen; Graeme N Smith
Journal:  BMJ Open       Date:  2016-07-07       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.